Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth

Creative Commons License

TOPALOĞLU R., GÜLHAN B., Celegen K., Inozu M., Hayran M., Duzoya A., ...Daha Fazla

FRONTIERS IN PEDIATRICS, cilt.7, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7
  • Basım Tarihi: 2019
  • Doi Numarası: 10.3389/fped.2019.00313
  • Dergi Adı: FRONTIERS IN PEDIATRICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: rituximab, nephrotic syndrome, steroid, cyclosporine, growth, MYCOPHENOLATE-MOFETIL, MULTICENTER, SAFETY
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background: Since the early 2000s rituximab (RTX) has been thought of as an alternative treatment for steroid-sensitive nephrotic syndrome (SSNS) and steroid-resistant nephrotic syndrome (SRNS).